DR GULVE HOLDING ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  0.3% 0.3% 0.3% 0.3% 0.3%  
Bankruptcy risk  1.5% 1.3% 1.4% 1.2% 1.2%  
Credit score (0-100)  77 78 78 80 82  
Credit rating  A A A A A  
Credit limit (kDKK)  94.7 248.8 223.7 584.0 589.8  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  1,186 590 405 348 507  
EBITDA  1,144 548 363 306 465  
EBIT  964 368 182 125 282  
Pre-tax profit (PTP)  4,934.3 4,765.5 216.8 4,362.3 2,545.9  
Net earnings  4,858.7 4,278.2 717.3 4,050.2 2,350.6  
Pre-tax profit without non-rec. items  4,934 4,765 217 4,362 2,546  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  6,751 6,571 6,390 6,210 6,214  
Shareholders equity total  20,658 23,236 22,254 24,604 21,854  
Interest-bearing liabilities  5,309 7,360 2,758 2,328 2,009  
Balance sheet total (assets)  32,385 31,578 25,650 27,290 24,769  

Net Debt  -6,092 -12,201 -10,304 -10,216 -6,044  
 
See the entire balance sheet

Volume 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,186 590 405 348 507  
Gross profit growth  51.9% -50.2% -31.4% -14.1% 46.0%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  32,385 31,578 25,650 27,290 24,769  
Balance sheet change%  32.2% -2.5% -18.8% 6.4% -9.2%  
Added value  1,144.0 548.1 362.6 305.6 465.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -1,845 -361 -361 -361 -179  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  81.3% 62.3% 45.0% 36.0% 55.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  22.5% 19.6% 15.0% 20.6% 11.6%  
ROI %  25.3% 21.9% 15.1% 20.7% 11.6%  
ROE %  23.8% 19.5% 3.2% 17.3% 10.1%  

Solidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  63.8% 73.6% 86.8% 90.2% 88.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -532.5% -2,226.1% -2,841.7% -3,343.6% -1,298.7%  
Gearing %  25.7% 31.7% 12.4% 9.5% 9.2%  
Net interest  0 0 0 0 0  
Financing costs %  32.5% 23.9% 80.3% 43.1% 21.4%  

Liquidity 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  2.2 3.7 23.0 35.8 32.7  
Current Ratio  2.2 3.7 23.0 35.8 32.7  
Cash and cash equivalent  11,401.5 19,561.2 13,062.6 12,544.9 8,052.6  

Capital use efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,356.3 -4,475.4 4,006.5 10,065.9 9,201.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  1,144 548 363 306 465  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1,144 548 363 306 465  
EBIT / employee  964 368 182 125 282  
Net earnings / employee  4,859 4,278 717 4,050 2,351